Access to anti-retroviral drugs, male in Bolivia, Plurinational State of
Bolivia, Plurinational State of: Access to anti-retroviral drugs, male was 59.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Bolivia, Plurinational State of, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Bolivia, Plurinational State of stood at 59.0%. That is the highest value across all 25 years on record.
The figure is up 5.4% on the previous year and up 321.4% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Bolivia, Plurinational State of peaked at 59.0% in 2024 and was at its lowest, 0.0%, in 2000.
Bolivia, Plurinational State of ranks 105th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Bolivia, Plurinational State of, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 1.0% | +0.0% |
| 2005 | 1.0% | +0.0% |
| 2006 | 2.0% | +100.0% |
| 2007 | 2.0% | +0.0% |
| 2008 | 3.0% | +50.0% |
| 2009 | 5.0% | +66.7% |
| 2010 | 5.0% | +0.0% |
| 2011 | 5.0% | +0.0% |
| 2012 | 9.0% | +80.0% |
| 2013 | 11.0% | +22.2% |
| 2014 | 14.0% | +27.3% |
| 2015 | 19.0% | +35.7% |
| 2016 | 23.0% | +21.1% |
| 2017 | 29.0% | +26.1% |
| 2018 | 35.0% | +20.7% |
| 2019 | 40.0% | +14.3% |
| 2020 | 44.0% | +10.0% |
| 2021 | 48.0% | +9.1% |
| 2022 | 50.0% | +4.2% |
| 2023 | 56.0% | +12.0% |
| 2024 | 59.0% | +5.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.5% | 0.0% | 5.0% | 10 |
| 2010s | 19.0% | 5.0% | 40.0% | 10 |
| 2020s | 51.4% | 44.0% | 59.0% | 5 |
Countries ranked near Bolivia, Plurinational State of
- 102 Albania 60.0% compare
- 102 Maldives 60.0% compare
- 102 North Macedonia 60.0% compare
- 105 Malaysia 59.0% compare
- 105 Syrian Arab Republic 59.0% compare
- 105 Venezuela, Bolivarian Republic of 59.0% compare
More gender data for Bolivia, Plurinational State of
- Child population (UN estimates and projections) 3,733 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.1438 % change on previous year (2030)
- Population 9,673 (2030)
- Working-age population (UN estimates and projections) 9,673 (2030)
- Population (UN estimates and projections), annual growth rate 1.64 % change on previous year (2030)
- Age population, age 00, female, interpolated 124,797 (2025)
- Age population, age 00, male, interpolated 129,451 (2025)
- Age population, age 01, female, interpolated 123,730 (2025)
- Age population, age 01, male, interpolated 128,219 (2025)
- Age population, age 02, female, interpolated 123,147 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Bolivia, Plurinational State of?
- Access to anti-retroviral drugs, male in Bolivia, Plurinational State of was 59.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Bolivia, Plurinational State of?
- The highest recorded value was 59.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Bolivia, Plurinational State of?
- The lowest recorded value was 0.0% in 2000.
- How does Bolivia, Plurinational State of rank for access to anti-retroviral drugs, male?
- Bolivia, Plurinational State of ranks 105th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Bolivia, Plurinational State of?
- Over the last ten years it is up 321.4%. The long-run trend across the full record is volatile.
- Where does this Bolivia, Plurinational State of data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.